Bone Disorders (OA/RA/OP) Flashcards

(41 cards)

1
Q

what are the characteristics of a joint in osteoarthtitis?

A

thickened capsule, cyst formation and sclerosis in subchondral bone, shelving ‘fibrillated’ cartilage, osteophytic lymphing, synovial hypertrophy, altered bone contour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what cartilage is primarily affected by OA, and how so?

A

articular cartilage
causes increased swelling, colour change, cartilage fibrillation, cartilage erosion down to subchondral bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the 3 types of cartilage?

A

hyaline (articular)
elastic (nose/ear)
fibrocartilage (meniscus/pubic ramus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what 2 things is cartilage made up of?

A

cells (chrondocytes)
extracellular matrix (collagen/water)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe the 3 layers of cartilage

A

superficial, middle and deep zone, all have different compositions of collagen and chondrocytes, calcified cartilage within

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe the function of the cartilage features

A

chondrocytes - synthesise and maintain ECM
ECM - collagen type 2 embedded in proteoglycan gel, protects chondrocytes from loading forces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what biological changes are seen in OA?

A

decreases in water content, proteoglycan synthesis, collagen cross linking and hyalauronic acid
trauma damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the primary and secondary types of OA?

A

primary - degenerative

secondary - trauma, hip dysplasia, infection, diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what may an x-ray find in OA?

A

LOSS
L - loss of joint space
O - osteophytes
S - subchondral sclerosis
S - subchondral cysts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what non-surgical treatments are administered for OA?

A

medications, physiotherapy, walking aids, joint injections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the surgical treatments administered for OA?

A

arthroscopy, cartilage transplantation, bone re-alignment, joint replacement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the principles of joint replacement surgery?

A

remove worn cartilage and replace with synthetic material
objective - pain relief, increase motion range, improve daily life activities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is autoimmunity?

A

loss of immunological tolerance to self

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe the basics of RA

A

widespread joint pain, stiffness and swelling leading to joint destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are some of the systemic symptoms of RA?

A

fevers, weight loss, extra-articular features (inflammation in other joints)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

name the 6 phases of RA development

A

genetic risk factors
environmental risk factors
autoimmunity
symptoms
undifferenciated arthritis
RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

where are most genes causing RA found?

A

in adaptive immunity pathways (B-cell, T-cell, cytokines)

18
Q

what environmental risk factor aggrevates the shared epitope (HLA-DRB1 allele)

19
Q

explain the physiological changes occuring in the autoimmunity stage of RA development

A

autoantibodies present (rheumatoid factor and CCP)
increased cytokines and chemokines
altered cholestorol metabolism

20
Q

explain the changes in the symptom phase of RA development causing the symptoms

A

monocytes/macrophages activated
and cytokine and chemokines release causing damage, meaning more self-antigens and epitope spread
local tissue environment takes over (osteoclasts)
inflammation becomes established

21
Q

what is the standard treatment for RA?

A

DMARDs (disease-modifying anti-rheumatic drugs) e.g methatrexate
NSAIDs
corticosteroids

22
Q

what are biologic agents?

A

drugs (e.g monoclonal antibodies) which have been developed rationally by targetting processes important in disease pathogenesis (e.g T-cells)

23
Q

what are the differences in using biologic drugs compared to conventional drugs?

A

biologics differ in size, manufacturing complexity, and in the way they interact with cells and other proteins in the body

24
Q

define OA

A

chronic degenerative change of damaged articular cartilage

25
what are the clinical features of OA?
pain (worse on weight bearing) night waking stiffness (often in morning) walking aid reliance loss of function
26
what is the clinical term for a joint replacement?
arthroplasty
27
what are the risks of an arthroplasty?
blood clots, infection, stiffness, ongoing pain, dislocation, leg length discrepancy, neurovascular damage, anaesthetic risk
28
what are the risk factors for OA?
age, sex (more likely in females), trauma (intra-articular fracture), microtrauma (repetitive high impact activities), genetics, congenital abnormality obesity
29
what is the function of articular cartilage?
smooth lubricated surface for articulation facilitate load transmission and lower impact movement
30
name the alternate medications used for articular cartilage repair
glucosamine and chondroitin sulfate
31
define osteoporosis (OP)
systemic skeletal disease characterised by low bone density and microarchitectual deterioration of bone tissue with a consequent increase in bone fragility
32
what is a fragility fracture?
fracture sustained by a fall from standing or less
33
what are the non-modifiable risk factors for OP?
age (65+ F, 75+ M) gender (F) race (caucasian) previous fracture early (untreated) menopause family history
34
what are the modifiable risk factors for OP?
bone mineral density alcohol (3.5+ units daily) low BMI (<20) smoking physical inactivity
35
name any OP related conditions
diabetes inflammatory rheumatic diseases GI conditions endocrine conditions chronic liver/kidney disease neuro - alzeimers/MS
36
compare FRAX and Q-fracture screening
FRAX (fracture risk assessment) - includes bone mass density (BMD) doesn't include several important variables Q-fracture - includes other factors but not BMD
37
explain the DXA scan
dual energy x-ray absorptiometry measures bone mineral density at spine and hip gives a T-score (for OP)
38
explain the T-score system of DXA screening
+1 to -1: normal range -1 to -2.5: osteopenia (slightly below normal) -2.5 and below: OP
39
describe how bisphosphonates work as a therapy for OP
inhibits osteoclasts high affinity for bone mineral
40
explain how denosumab acts as a therapy for OP
monoclonal antibody against receptor activator for RANK ligand (required for osteoclast function)
41
what are the 2 general treatment strategies for OP?
antiresorptive - reduces bone turnover anabolic - stimulates bone formation